Clinical Trial Update: Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ASN-3186 for patients with advanced solid tumors in Phase 1/2, sponsored by Jiangsu Yahong Meditech Co., Ltd (Asieris). The study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ASN-3186

Snippet

Sponsor: Jiangsu Yahong Meditech Co., Ltd aka Asieris | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING